Fiasp and the Onset 5 CSII Trial – What Novo Nordisk found
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]
If you’re a person with Type 1 Diabetes, it’s very hard not to have seen the news about Sir Michael Rawlins’ (Chair of the UK […]
If you keep your eyes on Diabetes and medical media, you can’t fail to have noticed that Roche’s Solo Micropump, a new patch pump from […]
Back at the end of March, when Dexcom launched the G6, I questioned how this might affect those using WeAreNotWaiting open source Diabetes technology. It […]
After six months of leaving Fiasp on the shelf, and occasionally using it as an adjunct injection when fast carbs were consumed (where it still […]
***Updated following clarification from the UK Distributor*** Whilst I recently tested and reported back on the Medtrum A6 CGM system, it’s not the only newcomer […]
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
After the initial couple of days with the Medtrum, and the data that was produced, I thought it would be a good idea to provide […]
Following the earlier article on what you get when you buy a Medtrum A6 CGM, let me precipitate this piece by mentioning that it contains […]
Copyright © 2026 | WordPress Theme by MH Themes